IPCA Laboratories Q2 Results
- BSE: 524494
- NSE: IPCALAB
- ISIN: INE571A01038
- Sector: Biotechnology & Drugs
BSE
1,606
15.45 (0.97%)
15.45 (0.97%)Volume21.76 K
Updated: Mon 25 Nov, 2024 | 15:29:24
NSE
1,607.1515.80 (0.99%)
15.80 (0.99%)Volume6.43 L
Updated: Mon 25 Nov, 2024 | 15:43:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹2,354.90 Cr.(12.53%)
- Operating Profit₹341.13 Cr.(16.10%)
- Profit After Tax₹229.48 Cr.(19.37%)
- Operating Margin14.49%(27.59%)
Note: Comparison is on YoY basis
Quarterly - IPCA Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2,354.90 | 1,587.58 | -% | 2,033.96 | -% |
| Selling/ General/ Admin Expenses Total | 509.84 | 357.51 | -% | 425.87 | -% |
| Depreciation/ Amortization | 100.35 | 69.27 | -% | 90.34 | -% |
| Other Operating Expenses Total | 645.02 | 407.12 | -% | 609.24 | -% |
| Total Operating Expense | 2,013.77 | 1,349.23 | -% | 1,803.03 | -% |
| Operating Income | 341.13 | 238.35 | -% | 230.93 | -% |
| Net Income Before Taxes | 344.83 | 251.82 | -% | 225.36 | -% |
| Net Income | 229.48 | 162.82 | -% | 145.06 | -% |
| Diluted Normalized EPS | 9.05 | 6.42 | -% | 5.72 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST